Ten years ago this October marked an exciting event for ARO: the launch of our inaugural issue! Thanks to a tremendous team of board members, peer reviewers, managing editor, and dedicated supporters like yourselves, we have expanded from an online-only publication to both a print and web-based journal, offering numerous new features and improvements over the years. These updates include free webinars and SA-CME opportunities, introduction of research articles, a double-blind peer review system with an ever-growing panel of vetted peer reviewers, the Resident Voice editorial from ARRO leadership, biweekly enewsletters summarizing industry news, the ARO Insights blog, a climbing social media presence thanks to your support, and much more. We are very proud and grateful for how ARO has evolved over the past decade!
To commemorate our 10-year milestone, ARO has updated its look, enhancing readability with artful uses of white space, color, and a modernized layout. We hope you enjoy the fresh new design, which is also featured in our sister publication, Applied Radiology, celebrating a whopping 50 years of service.
While change is good and enlists its share of excitement, dependability strengthens trust. In every issue, ARO provides a steadfast array of quality editorial content to aid in the management and treatment of cancer patients. In this issue, which focuses on the promising field of MR-guided radiation therapy, we owe a special thanks to Stephen Rosenberg, MD, director of MRgRT at Moffit Cancer Center, for developing a fantastic lineup on the topic. Included are three comprehensive, SA-CME-accredited review articles on: MR guidance in SBRT for lung cancer treatment, advantages and limitations of integrating MRgRT into practice, and MRgRT for oligometastatic cancer. The issue also features a well-written research article comparing provider costs of MRgRT with CTgRT for prostate SBRT delivery at a single institution. Adding to the theme is a Technology Trends article in which industry/clinical experts discuss the two primary MRgRT systems, time and workload needs, ablative doses, and future directions.
We are also delighted to present the webinar, MR-Guided Radiotherapy: Patient Selection and New Opportunities, which is moderated by Dr. Rosenberg and will complement the issue theme. This will be held on September 29th and archived afterward at https://appliedradiationoncology.com/webinars/on-demand. The webinar is free and features four expert panelists. We hope you can join us!
In addition to the MRgRT focus, this issue also features: Analysis of the Radiation Oncology In-Training Examination Content Using a Clinical Care Path Conceptual Framework, an excellent research article that challenges the current approach to residency education; the Resident Voice column, Improving Cancer Equity Through Advocacy, which amplifies the critical need to address disparities in our healthcare system; and two interesting case reports: Efficacy of Stereotactic Radiotherapy in Recurrent Intrahepatic Cholangiocarcinoma and Radiation Therapy in the Treatment of Plantar Fibromatosis.
We hope you enjoy this issue and greatly appreciate your loyal support over the past decade! We look forward to your continued readership and hope to influence and optimize the use of radiation oncology, a highly effective treatment for many patients.Back To Top
Suh J. Celebrating 10 Years . Appl Rad Oncol. 2021;10(3):4.
Dr. Suh is the Editor-in-Chief of Applied Radiation Oncology, and Professor and Chairman, Department of Radiation Oncology at the Taussig Cancer Institute, Rose Ella Burkhardt Brain Tumor and Neuro-oncology Center, Cleveland Clinic, Cleveland, OH